Milnacipran

Start

Disclaimer

Sitemap alfabetisch Classificatie  Cvs-ME CVS Adolescenten CVS ME Algemeen
CVS-Archieven CVS Behand-Onderzoek CVS Bloedtesten CVS Congressen CVS DiŽten CVS Geneesheren
CVS Geneesmiddelen CVS Immunologie CVS-Juridisch CVS Kenmerken CVS Massage CVS Pijn-Pain
CVS-Psychisch CVS Orthomoleculair CVS Osteopathie CVS Terminologie CVS Verwante ziektes CVS- Virussen

CVS -Acupunctuur CVS Alternatief CVS Chinese geneeswijzen CVS Chiropractor CVS-Cultuur
CVS-Fibromyalgie CVS-Homeopathie CVS-Kinesiologie CVS Kinesitherapie CVS Manuele therapie CVS-Publicaties
CVS Seksualiteit CVS-TandhygiŽne CVS-Toerisme CVS-Websites CVS Werelddag Antwerp  

  

CVS Verz. maatschappijen CVS-Verzekeringen CVS-Verz.-geneeskunde Gewaarborgd inkomen CVS Gew.inkomen

CVS Medische expertise CVS Minnel.med.expertise Medische Maffia    

Start
Omhoog

 

Milnacipran:

 

 

http://www.cypressbio.com/corp/health/
milbackground.jsp

Milnacipran background

http://www.immunesupport.com/library/
bulletinarticle.cfm?ID=5251&PROD=PH119

Milnacipran Clinical Study Demonstrates Effective Treatment of Fibromyalgia Pain is Distinct from Treatment of Mood

http://www.cypressbio.com/corp/health/
milbackground.jsp

Cypress Bioscience, Inc.recently completed a Phase II clinical trial evaluating the first NSRI, milnacipran, as an oral treatment for FMS. In this study, milnacipran was shown to statistically improve a number of primary and secondary hallmark symptoms of fibromyalgia.

 

 

Artikelen:

 

Drug Milnacipran demonstrates efficacy in cognitive performance animal model

Milnacipran Clinical study demonstrates effective treatment of fibromyalgia pain